[May 21-26, 2012]
DNDi-MSF press briefing
MONDAY, MAY 21, 2012, 11:00 AM
[May 21-26, 2012]
[May 18, 2012]
DNDi attended this informal meeting organized by the Brazilian Health Surveillance Agency (ANVISA) and the WHO, previous to the World Health Assembly.
[April 24-26, 2012]
Cape Town, South Africa
The Council on Health Research and Development Group (The COHRED Group) in collaboration with partners and Governments, launched a new series of Global Forum for Health Research meetings on the theme: ‘Beyond aid…research and innovation as key drivers of health, equity and development’.
[April 18-21, 2012]
Giving voice to the frontliners of health, this year’s edition of the GHF focuses on chronic conditions. DNDi and MSF co-hosted a session on adult chronic Chagas disease.
[January 30, 2012]
A group of international partners announced a new, coordinated push to accelerate progress toward eliminating or controlling 10 neglected tropical diseases (NTDs) by the end of the decade. Uniting efforts with NTD-endemic countries, partners pledged to bring a unique focus to defeating these diseases and to work together to improve the lives of the 1.4 billion people worldwide affected by NTDs.
[December 4-8, 2011]
DNDi participated with presentations on the Leishmaniasis East Africa Platform and on Chagas disease, as well as with several posters and a DNDi booth.
[December 2, 2011]
‘Moving Innovation to Access for Neglected Patients’
Rio de Janeiro, Brazil
This year marks nearly a decade of progress since the foundations for DNDi were set forth at a remarkable meeting in Rio in 2002. Just nine years later, we come together again to review DNDi’s progress in bringing new treatments to neglected patients as well as to evaluate the main challenges in access to new tools.
[December 1st, 2011]
Rio de Janeiro
The meeting “Artesunate-Mefloquine (ASMQ) Fixed-Dose Combination (FDC), an additional tool in the armamentarium to control malaria in Latin-America” was held in parallel with DNDi‘s annual partners’ meeting in Rio de Janeiro.
[October 23-26, 2011]
DNDi co-organized a session on Product Development for Neglected Patients and took part to the Innovation session.
Check here for the detailed presentation of the symposia, with speakers.
[October 9 – 12, 2011]
Addis Ababa, Ethiopia
DNDi attended the Forum whose theme for 2011 was “Strengthening Research Partnerships for Better Health and Sustainable Development”
[October 3-6, 2011]
At this major European conference, DNDi organized symposia on kinetoplatid diseases and VL-HIV co-infection. Bernard Pécoul spoke in a plenary session (video accessible here) on ‘The Science of Elimination’.
[Sept 21-23, 2011]
All key LEAP platform members gathered to share recent progress in the field of Visceral Leishmaniasis.
[September 12-16, 2011]
DNDi attended the 31st Conference of the International Scientific Council for Trypanosomiasis Research and Control (ISCTRC) in the session on HAT chemotherapy.
[July 17-20, 2011]
With the expansion of its portfolio to paediatric HIV, DNDi attended the IAS conference to advocate on R&D needs for better adapted drugs for infants
[July 8-10, 2011]
DNDi attended the firsts NTD meeting of ISID in the following sessions: “Developing the Tools Needed to Fight NTDs” and “Essential Elements: Drug Donations and Nongovernmental Development Programs”
[January 24, 2011]
Drugs for Neglected Diseases initiative (DNDi) and Cipla, jointly with Vimal, organised a symposium to discuss the use of Artemisin Combination Therapy in Myanmar.
[December 4, 2010]
New Delhi, India
In collaboration with partners from the Program on Global health and Technology Access of Duke University, DNDi organized a workshop on intellectual property and open innovation on 4th December 2010 in New Delhi, India. The workshop gathered around 50 participants including DNDi partners, representatives of Indian civil society and DNDi staff.
[December 3, 2010]
New Delhi, India
Like in 2009 in Nairobi, Drugs for Neglected Diseases initiative (DNDi) brought together more than 150 Indian and international health researchers, policy makers, experts from 22 countries on December 3rd, at the Constitutional Club in New Delhi for the 3rd International Partners meeting organized by DNDi in collaboration with Indian Council for Medical Research (ICMR), to stimulate greater regional research partnership to fight the most neglected diseases such as Kala-azar sleeping sickness, malaria and Chagas disease.
[November 3-7, 2010]
The Drugs for Neglected Diseases initiative (DNDi) will participate in several activities at ASTMH 2010, including a joint symposium with Central Drug Research Institute (CDRI) on Visheral Leishmaniasis (VL) in the Indian Continent, a second symposium on VL in East Africa, a satellite symposium on Challenges and Successes of the FACT Project through Innovative Partnerships for the development of Artesunate Combination Therapies for Malaria, as well as several oral presentations.
[August 15-20, 2010]
The Drugs for Neglected Diseases initiative (DNDi) participated in several activities at the XIIth International Congress of Parasitology (ICOPA) 2010: the organisation of two symposia, (Malaria and Drug Discovery), as well as a preview of the documentary “1$ for 1 life“.